• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CB2 和 TRPV1 刺激对小儿炎症性肠病中铁诱导的破骨细胞过度活跃的影响。

Effects of CB2 and TRPV1 Stimulation on Osteoclast Overactivity Induced by Iron in Pediatric Inflammatory Bowel Disease.

机构信息

Department of Woman, Child and General and Specialist Surgery, University of Campania "Luigi Vanvitelli," Naples, Italy.

Department of Experimental Medicine, University of Campania "Luigi Vanvitelli," Naples, Italy.

出版信息

Inflamm Bowel Dis. 2022 Aug 1;28(8):1244-1253. doi: 10.1093/ibd/izac073.

DOI:10.1093/ibd/izac073
PMID:35472140
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9340523/
Abstract

BACKGROUND

The reduction of bone mineral density and osteoporosis have high impacts on the health of patients with inflammatory bowel diseases (IBD). We have previously shown that a dysregulated iron metabolism occurs in IBD and leads to a decrease in circulating iron concentration and excessive intracellular sequestration of iron. Studies suggest that iron overload significantly affects the bone, accelerating osteoclast (OC) differentiation and activation, promoting bone resorption. Moreover, we demonstrated that iron overload causes OC overactivity. The cannabinoid receptor type 2 (CB2) and the transient receptor potential vanilloid type-1 (TRPV1) are potential therapeutic targets for bone diseases. The aim of this study was to evaluate the roles of CB2 and TRPV1 receptors and of iron in the development of osteoporosis in pediatric IBD.

METHODS

We differentiated OCs from peripheral blood mononuclear cells of patients with IBD and healthy donors and evaluated CB2 and TRPV1 receptor expression; OC activity, and iron metabolism by Western blot, TRAP assays, bone resorption assays, and iron assays. Moreover, we analyzed the effects of the pharmacological modulation of CB2 and TRPV1 receptors on OC activity and on the iron metabolism.

RESULTS

We confirmed the well-known roles of CB2 and TRPV1 receptors in bone metabolism and suggested that their stimulation can reduce the OC overactivity induced by iron, providing new insights into the pathogenesis of pediatric IBD-related bone resorption.

CONCLUSIONS

Stimulation of CB2 and TRPV1 could reduce IBD-related osteoporosis due to their direct effects on OC activity and to modulating the iron metabolism.

摘要

背景

骨密度降低和骨质疏松症对炎症性肠病(IBD)患者的健康有很大影响。我们之前已经表明,IBD 中存在铁代谢失调,导致循环铁浓度降低和铁的细胞内过度蓄积。研究表明,铁过载会显著影响骨骼,加速破骨细胞(OC)分化和激活,促进骨质吸收。此外,我们还证明了铁过载会导致 OC 过度活跃。大麻素受体 2(CB2)和瞬时受体电位香草醛型 1(TRPV1)是骨疾病的潜在治疗靶点。本研究旨在评估 CB2 和 TRPV1 受体以及铁在小儿 IBD 中骨质疏松症发展中的作用。

方法

我们从 IBD 患者和健康供体的外周血单核细胞中分化 OC,并通过 Western blot、TRAP 测定、骨吸收测定和铁测定评估 CB2 和 TRPV1 受体表达、OC 活性和铁代谢。此外,我们分析了 CB2 和 TRPV1 受体的药理学调节对 OC 活性和铁代谢的影响。

结果

我们证实了 CB2 和 TRPV1 受体在骨代谢中的已知作用,并提出其刺激可减少铁诱导的 OC 过度活跃,为小儿 IBD 相关骨吸收的发病机制提供了新的见解。

结论

刺激 CB2 和 TRPV1 可能会减少 IBD 相关的骨质疏松症,因为它们直接作用于 OC 活性并调节铁代谢。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbd7/9340523/a5fc09c58e32/izac073f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbd7/9340523/c756aab1cf3c/izac073f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbd7/9340523/5726dbc1fc4a/izac073f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbd7/9340523/5e7ea6caa646/izac073f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbd7/9340523/826259fe62a5/izac073f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbd7/9340523/1242dc61b900/izac073f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbd7/9340523/a5fc09c58e32/izac073f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbd7/9340523/c756aab1cf3c/izac073f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbd7/9340523/5726dbc1fc4a/izac073f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbd7/9340523/5e7ea6caa646/izac073f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbd7/9340523/826259fe62a5/izac073f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbd7/9340523/1242dc61b900/izac073f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbd7/9340523/a5fc09c58e32/izac073f0006.jpg

相似文献

1
Effects of CB2 and TRPV1 Stimulation on Osteoclast Overactivity Induced by Iron in Pediatric Inflammatory Bowel Disease.CB2 和 TRPV1 刺激对小儿炎症性肠病中铁诱导的破骨细胞过度活跃的影响。
Inflamm Bowel Dis. 2022 Aug 1;28(8):1244-1253. doi: 10.1093/ibd/izac073.
2
Alteration of osteoclast activity in childhood cancer survivors: Role of iron and of CB2/TRPV1 receptors.儿童癌症幸存者破骨细胞活性的改变:铁和 CB2/TRPV1 受体的作用。
PLoS One. 2022 Jul 21;17(7):e0271730. doi: 10.1371/journal.pone.0271730. eCollection 2022.
3
Iron overload causes osteoporosis in thalassemia major patients through interaction with transient receptor potential vanilloid type 1 (TRPV1) channels.铁过载通过与瞬时受体电位香草酸亚型1(TRPV1)通道相互作用,导致重型地中海贫血患者发生骨质疏松。
Haematologica. 2014 Dec;99(12):1876-84. doi: 10.3324/haematol.2014.104463. Epub 2014 Sep 12.
4
PKCβII-mediated cross-talk of TRPV1/CB2 modulates the glucocorticoid-induced osteoclast overactivity.蛋白激酶CβII介导的瞬时受体电位香草酸亚型1/大麻素受体2相互作用调节糖皮质激素诱导的破骨细胞过度活化。
Pharmacol Res. 2017 Jan;115:267-274. doi: 10.1016/j.phrs.2016.11.039. Epub 2016 Dec 2.
5
The Role of Mifamurtide in Chemotherapy-induced Osteoporosis of Children with Osteosarcoma.米伐木肽在骨肉瘤患儿化疗性骨质疏松中的作用。
Curr Cancer Drug Targets. 2017;17(7):650-656. doi: 10.2174/1568009616666161215163426.
6
The genetic ablation or pharmacological inhibition of TRPV1 signalling is beneficial for the restoration of quiescent osteoclast activity in ovariectomized mice.TRPV1信号的基因消融或药理学抑制有利于去卵巢小鼠静止破骨细胞活性的恢复。
Br J Pharmacol. 2014 May;171(10):2621-30. doi: 10.1111/bph.12542.
7
The endovanilloid/endocannabinoid system in human osteoclasts: possible involvement in bone formation and resorption.人类破骨细胞中的内源性香草酸/内源性大麻素系统:可能参与骨形成与骨吸收。
Bone. 2009 Mar;44(3):476-84. doi: 10.1016/j.bone.2008.10.056. Epub 2008 Nov 14.
8
CB(2) and TRPV(1) receptors oppositely modulate in vitro human osteoblast activity.CB(2)和TRPV(1)受体对体外培养的人成骨细胞活性具有相反的调节作用。
Pharmacol Res. 2015 Sep;99:194-201. doi: 10.1016/j.phrs.2015.06.010. Epub 2015 Jun 25.
9
The Role of Cannabinoid Receptor Type 2 in the Bone Loss Associated With Pediatric Celiac Disease.大麻素受体 2 型在与小儿乳糜泻相关的骨丢失中的作用。
J Pediatr Gastroenterol Nutr. 2020 Nov;71(5):633-640. doi: 10.1097/MPG.0000000000002863.
10
The Endocannabinoid/Endovanilloid System in Bone: From Osteoporosis to Osteosarcoma.内源性大麻素/内香草素系统在骨骼中的作用:从骨质疏松症到骨肉瘤。
Int J Mol Sci. 2019 Apr 18;20(8):1919. doi: 10.3390/ijms20081919.

引用本文的文献

1
Interactions Between Iron Metabolism and the Endocannabinoid System in Bacterial Infections.细菌感染中铁代谢与内源性大麻素系统之间的相互作用
Antibiotics (Basel). 2025 Jun 18;14(6):614. doi: 10.3390/antibiotics14060614.
2
Effects of CB2 Receptor Modulation on Macrophage Polarization in Pediatric Inflammatory Bowel Disease.CB2受体调节对小儿炎症性肠病中巨噬细胞极化的影响。
Int J Mol Sci. 2025 Apr 15;26(8):3720. doi: 10.3390/ijms26083720.
3
Molecular mechanisms and treatment strategies for estrogen deficiency-related and glucocorticoid-induced osteoporosis: a comprehensive review.

本文引用的文献

1
Gut-innervating TRPV1+ Neurons Drive Chronic Visceral Pain via Microglial P2Y12 Receptor.肠道传入 TRPV1+神经元通过小胶质细胞 P2Y12 受体驱动慢性内脏痛。
Cell Mol Gastroenterol Hepatol. 2022;13(4):977-999. doi: 10.1016/j.jcmgh.2021.12.012. Epub 2021 Dec 24.
2
Cannabis and Its Potential Protective Role Against Inflammatory Bowel Disease: A Scoping Review.大麻及其对炎症性肠病的潜在保护作用:一项范围综述。
Cureus. 2021 Oct 17;13(10):e18841. doi: 10.7759/cureus.18841. eCollection 2021 Oct.
3
Emerging Comorbidities in Inflammatory Bowel Disease: Eating Disorders, Alcohol and Narcotics Misuse.
雌激素缺乏相关和糖皮质激素诱导性骨质疏松症的分子机制与治疗策略:综述
Inflammopharmacology. 2025 Apr 28. doi: 10.1007/s10787-025-01749-3.
4
Cannabinoid Receptor Type 2 Agonist, GW405833, Reduced the Impacts of MDA-MB-231 Breast Cancer Cells on Bone Cells.大麻素2型受体激动剂GW405833减轻了MDA-MB-231乳腺癌细胞对骨细胞的影响。
Cancer Med. 2025 Feb;14(4):e70709. doi: 10.1002/cam4.70709.
5
TRPV1 Regulates Proinflammatory Properties of M1 Macrophages in Periodontitis Via NRF2.TRPV1 通过 NRF2 调节牙周炎中 M1 巨噬细胞的促炎特性。
Inflammation. 2024 Dec;47(6):2041-2056. doi: 10.1007/s10753-024-02024-3. Epub 2024 May 3.
6
Role of Iron Accumulation in Osteoporosis and the Underlying Mechanisms.铁蓄积在骨质疏松症中的作用及其潜在机制。
Curr Med Sci. 2023 Aug;43(4):647-654. doi: 10.1007/s11596-023-2764-z. Epub 2023 Jun 16.
7
CB2 Receptor as Emerging Anti-Inflammatory Target in Duchenne Muscular Dystrophy.大麻素 CB2 受体作为杜氏肌营养不良症中新兴的抗炎靶点。
Int J Mol Sci. 2023 Feb 7;24(4):3345. doi: 10.3390/ijms24043345.
8
Emerging Roles of the Iron Chelators in Inflammation.铁螯合剂在炎症中的新作用。
Int J Mol Sci. 2022 Jul 20;23(14):7977. doi: 10.3390/ijms23147977.
炎症性肠病中的新兴共病:饮食失调、酒精和麻醉品滥用。
J Clin Med. 2021 Oct 8;10(19):4623. doi: 10.3390/jcm10194623.
4
Inflammatory Bowel Disease and Cannabis: A Practical Approach for Clinicians.炎症性肠病与大麻:临床医师实用指南。
Adv Ther. 2021 Jul;38(7):4152-4161. doi: 10.1007/s12325-021-01805-8. Epub 2021 Jun 10.
5
Interleukin 6: Biological significance and role in inflammatory bowel diseases.白细胞介素 6:在炎症性肠病中的生物学意义和作用。
Adv Clin Exp Med. 2021 Apr;30(4):465-469. doi: 10.17219/acem/130356.
6
Hepcidin Is a Reliable Marker of Iron Deficiency Anemia in Newly Diagnosed Patients with Inflammatory Bowel Disease.铁调素是炎症性肠病初诊患者缺铁性贫血的可靠标志物。
Dis Markers. 2020 Nov 28;2020:8523205. doi: 10.1155/2020/8523205. eCollection 2020.
7
Silencing of lipocalin-2 improves cardiomyocyte viability under iron overload conditions via decreasing mitochondrial dysfunction and apoptosis.沉默脂联素-2 通过减少线粒体功能障碍和细胞凋亡改善铁过载条件下的心肌细胞活力。
J Cell Physiol. 2021 Jul;236(7):5108-5120. doi: 10.1002/jcp.30219. Epub 2020 Dec 15.
8
Cannabis in Gastroenterology: Watch Your Head! A Review of Use in Inflammatory Bowel Disease, Functional Gut Disorders, and Gut-Related Adverse Effects.胃肠病学中的大麻:小心你的脑袋!关于其在炎症性肠病、功能性肠道疾病及肠道相关不良反应中应用的综述
Curr Treat Options Gastroenterol. 2020;18(4):519-530. doi: 10.1007/s11938-020-00323-w. Epub 2020 Nov 21.
9
The Role of Cannabinoid Receptor Type 2 in the Bone Loss Associated With Pediatric Celiac Disease.大麻素受体 2 型在与小儿乳糜泻相关的骨丢失中的作用。
J Pediatr Gastroenterol Nutr. 2020 Nov;71(5):633-640. doi: 10.1097/MPG.0000000000002863.
10
Biomarkers of Inflammation in Inflammatory Bowel Disease: How Long before Abandoning Single-Marker Approaches?炎症性肠病的炎症生物标志物:单标志物方法需要多久才能被放弃?
Dig Dis. 2021;39(3):190-203. doi: 10.1159/000511641. Epub 2020 Sep 17.